These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21894485)

  • 21. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
    Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiological and behavioral output of the rat basal ganglia after intrastriatal infusion of d-amphetamine: lack of support for the basal ganglia model.
    Waszczak BL; Martin L; Boucher N; Zahr N; Sikes RW; Stellar JR
    Brain Res; 2001 Nov; 920(1-2):170-82. PubMed ID: 11716823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylphenidate produces selective enhancement of declarative memory consolidation in healthy volunteers.
    Linssen AM; Vuurman EF; Sambeth A; Riedel WJ
    Psychopharmacology (Berl); 2012 Jun; 221(4):611-9. PubMed ID: 22169884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personality factors moderate subjective and psychophysiological responses to d-amphetamine in humans.
    Hutchison KE; Wood MD; Swift R
    Exp Clin Psychopharmacol; 1999 Nov; 7(4):493-501. PubMed ID: 10609984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are attention lapses related to d-amphetamine liking?
    McCloskey M; Palmer AA; de Wit H
    Psychopharmacology (Berl); 2010 Feb; 208(2):201-9. PubMed ID: 19936714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rewarding effects of physical activity predict sensitivity to the acute subjective effects of d-amphetamine in healthy volunteers.
    Pester MS; Kirkpatrick MG; Geary BA; Leventhal AM
    J Psychopharmacol; 2018 Mar; 32(3):302-308. PubMed ID: 29338486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Riluzole and D-amphetamine interactions in humans.
    Sofuoglu M; Waters AJ; Mooney M; Kosten T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):16-22. PubMed ID: 17714844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triazolam-amphetamine interaction: dissociation of effects on memory versus arousal.
    Mintzer MZ; Griffiths RR
    J Psychopharmacol; 2003 Mar; 17(1):17-29. PubMed ID: 12680736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Social defeat stress, sensitization, and intravenous cocaine self-administration in mice.
    Yap JJ; Miczek KA
    Psychopharmacology (Berl); 2007 Jun; 192(2):261-73. PubMed ID: 17297635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary cadmium exposure attenuates D-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity.
    Miller DK; Dopheide MM; Smith SM; Casteel SW
    Pharmacol Biochem Behav; 2005 Apr; 80(4):557-66. PubMed ID: 15820525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute doses of d-amphetamine and bupropion increase cigarette smoking.
    Cousins MS; Stamat HM; de Wit H
    Psychopharmacology (Berl); 2001 Sep; 157(3):243-53. PubMed ID: 11605079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.
    Drevets WC; Gautier C; Price JC; Kupfer DJ; Kinahan PE; Grace AA; Price JL; Mathis CA
    Biol Psychiatry; 2001 Jan; 49(2):81-96. PubMed ID: 11164755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neural activation to monetary reward is associated with amphetamine reward sensitivity.
    Crane NA; Gorka SM; Weafer J; Langenecker SA; de Wit H; Phan KL
    Neuropsychopharmacology; 2018 Jul; 43(8):1738-1744. PubMed ID: 29581536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single dose of prednisone does not induce amphetamine-like subjective effects in healthy subjects.
    Warot D; Danjou P; Payan C; Rocher J; Brialy N; Puech AJ
    Therapie; 1995; 50(4):307-12. PubMed ID: 7482385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amphetamine-induced dopamine release and neurocognitive function in treatment-naive adults with ADHD.
    Cherkasova MV; Faridi N; Casey KF; O'Driscoll GA; Hechtman L; Joober R; Baker GB; Palmer J; Dagher A; Leyton M; Benkelfat C
    Neuropsychopharmacology; 2014 May; 39(6):1498-507. PubMed ID: 24378745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans.
    Kollins SH; Rush CR
    Pharmacol Biochem Behav; 1999 Oct; 64(2):319-26. PubMed ID: 10515308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OPRM1 gene variants modulate amphetamine-induced euphoria in humans.
    Dlugos AM; Hamidovic A; Hodgkinson C; Shen PH; Goldman D; Palmer AA; de Wit H
    Genes Brain Behav; 2011 Mar; 10(2):199-209. PubMed ID: 21029375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early ontogeny of D-amphetamine-induced one-trial behavioral sensitization.
    McDougall SA; Nuqui CM; Quiroz AT; Martinez CM
    Pharmacol Biochem Behav; 2013 Mar; 104():154-62. PubMed ID: 23360956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Setting the beat of an internal clock: Effects of dexamphetamine on different interval ranges of temporal processing in healthy volunteers.
    Graham-Schmidt KT; Martin-Iverson MT; Waters FAV
    Psych J; 2019 Mar; 8(1):90-109. PubMed ID: 30793518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conditioned changes in dopamine oxidation currents in the nucleus accumbens of rats by stimuli paired with self-administration or yoked-administration of d-amphetamine.
    Di Ciano P; Blaha CD; Phillips AG
    Eur J Neurosci; 1998 Mar; 10(3):1121-7. PubMed ID: 9753180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.